Quilizumab
| Monoclonal antibody | |
|---|---|
| Type | Whole antibody | 
| Source | Humanized (from mouse) | 
| Target | IGHE | 
| Clinical data | |
| ATC code | 
 | 
| Identifiers | |
| CAS Number | |
| ChemSpider | 
 | 
| UNII | |
| KEGG | |
| Chemical and physical data | |
| Formula | C6492H10046N1728O2023S44 | 
| Molar mass | 146082.49 g·mol−1 | 
Quilizumab (INN) is a humanized monoclonal antibody designed for the treatment of asthma. It binds to IGHE.
This drug was developed by Genentech.